Patents by Inventor Ninus Caram-Lelham

Ninus Caram-Lelham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9061016
    Abstract: A liquid composition that is an aqueous solution of a compound of formula (I), wherein the aqueous solution has a pH from about 3.0 to about 5.0. The liquid composition may be used in the treatment of a disorder selected from hyperproliferative diseases, autoimmune diseases and heart diseases.
    Type: Grant
    Filed: January 21, 2011
    Date of Patent: June 23, 2015
    Assignee: APREA AB
    Inventors: Styrbjorn Bystrom, Charlotta Liljebris, Ninus Caram-Lelham
  • Publication number: 20120289503
    Abstract: A liquid composition that is an aqueous solution of a compound of formula (I), wherein the aqueous solution has a pH from about 3.0 to about 5.0. The liquid composition may be used in the treatment of a disorder selected from hyperproliferative diseases, autoimmune diseases and heart diseases.
    Type: Application
    Filed: January 21, 2011
    Publication date: November 15, 2012
    Applicant: APREA AB
    Inventors: Styrbjorn Bystrom, Charlotta Liljebris, Ninus Caram-Lelham
  • Publication number: 20100279952
    Abstract: The invention relates to a biocompatible metastable intermediate material for controlling the mobility of at least one biologically active substance. An example of the invention is a hydrogel formed by cross-linked sodium hyaluronate treated with an oxidizing agent so as to open sugar rings and form aldehyde groups. The gel according to the invention is sterilized, e.g. by autoclaving.
    Type: Application
    Filed: December 22, 2008
    Publication date: November 4, 2010
    Inventors: Ninus Caram-Lelham, Ulf Winter, Bengt Agerup
  • Publication number: 20080312739
    Abstract: The invention relates to an implantable combination comprising a barrier (12), and a macromolecular bio-compatible material (14). The barrier (12) is porous to allow moieties of the macromolecular bio-compatible material (14), when implanted, to be exposed through the barrier, whereby the surface of the barrier is experienced by the body as an essentially non-foreign object. It also relates to an implant made from a barrier material and a bio-compatible material, the implant being suitable as e.g. a breast implant.
    Type: Application
    Filed: June 15, 2007
    Publication date: December 18, 2008
    Applicant: Q-Med AB
    Inventors: Bengt Agerup, Ninus Caram-Lelham, Ulf Winter